CytoSMART Technologies Joins the Axion BioSystems Brand
The news, which follows the company’s 2022 acquisition of CytoSMART Technologies, reflects Axion’s expanding portfolio of live-cell analysis tools for researchers in stem cell biology, immuno-oncology, neurology, virology, toxicology, and other fields. As we continue to grow our product portfolio, we seek to create a complete lab solution with systems and software that complement each other and operate seamlessly together. The acquisition of CytoSMART Technologies last year unlocked great potential and with this brand integration we see the next step forward in realizing our vision.” As part of the full integration, CytoSMART Technologies’ popular live-cell imaging platforms, such as the Omni, will be sold under the Axion BioSystems banner. Axion BioSystems is a leading life science company focused on next-generation live-cell analysis tools for biomedical research and drug discovery. With innovative systems that monitor complex cellular activity in real time without disturbing the underlying biology, Axion’s technology accelerates scientific discovery with streamlined workflows providing more complete datasets.
AI & Machine learning
Web and Content Management
Virtualization & Cloud Resources
Networking and Cloud